Pilot study to assess the efficacy of botulinum Toxin B (Myobloc) treatment of paravertebral muscles on pain and disability in subjects suffering from acute low back pain
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Botulinum toxin B (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 09 Mar 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov record.
- 30 May 2007 Status changed from recruiting to initiated.
- 21 Dec 2006 New trial record.